Biomerieux (BIM.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 3,979,900 | 3,674,600 | 3,589,000 | 3,376,200 | 3,118,100 |
| Cost of Goods | 1,764,600 | 1,617,400 | 1,580,400 | 1,412,500 | 1,364,500 |
| Gross Profit | 2,215,300 | 2,057,200 | 2,008,600 | 1,963,700 | 1,753,600 |
| Operating Expenses | 1,577,400 | 1,488,300 | 1,344,900 | 1,162,700 | 1,157,700 |
| Operating Income | 637,900 | 568,900 | 663,700 | 801,000 | 595,900 |
| Interest Expense | 16,000 | 4,400 | 4,100 | 9,100 | 24,900 |
| Other Income | -42,600 | -127,000 | -79,100 | -17,600 | -45,600 |
| Pre-tax Income | 579,300 | 437,500 | 580,500 | 774,300 | 525,400 |
| Income Tax | 154,300 | 114,500 | 140,100 | 175,600 | 121,500 |
| Net Income Continuous | 425,000 | 323,000 | 440,400 | 598,000 | 403,700 |
| Minority Interests | 7,100 | 34,800 | 11,800 | 2,900 | 1,700 |
| Net Income | $432,200 | $357,600 | $452,400 | $601,100 | $404,400 |
| EPS Basic Total Ops | 3.67 | 3.03 | 3.84 | 5.08 | 3.42 |
| EPS Basic Continuous Ops | 3.67 | 3.03 | 3.84 | 5.08 | 3.42 |
| EPS Diluted Total Ops | 3.64 | 3.01 | 3.82 | 5.06 | 3.41 |
| EPS Diluted Continuous Ops | 3.64 | 3.01 | 3.82 | 5.06 | 3.41 |
| EBITDA(a) | $897,500 | $700,800 | $861,600 | $1,014,400 | $761,100 |